Article
Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent.
Pediatric hematology and oncology - 1 Oct 2021
Mahat Upendra, Ambani Nila Mistry, Rotz Seth J, Radhakrishnan Kadakkal
Abstract excerpt
Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is an immune checkpoint, which downregulates T cell activation and T regulatory cell function. CTLA4 haploinsufficiency (CTLA4 HI) leads to T cell hyperactivation, immunodeficiency and variable degree of immune dysregulation. Furthermore, CTLA4 HI predisposes affected individuals to development of various cancers. Less well understood is the penetrance and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
